Thus, although type 2 diabetes and GSDI appear to be opposite diseases in terms of glucose production and insulin sensitivity, the liver is chronically exposed to either hyperglycemia or G6P accumulation, respectively, leading the same metabolic consequences, in particular hepatic steatosis (Figure 2). This evidence concerns the gene INS and Hyperglycemia.